Development of VEGFR2-specific Nanobody Pseudomonas exotoxin A conjugated to provide efficient inhibition of tumor cell growth.

Behdani, Mahdi

Development of VEGFR2-specific Nanobody Pseudomonas exotoxin A conjugated to provide efficient inhibition of tumor cell growth. [electronic resource] - New biotechnology Jan 2013 - 205-9 p. digital

Publication Type: Journal Article

1876-4347

10.1016/j.nbt.2012.09.002 doi


ADP Ribose Transferases--pharmacology
Bacterial Toxins--pharmacology
Cell Proliferation--drug effects
Chromatography, Gel
Enzyme-Linked Immunosorbent Assay
Exotoxins--pharmacology
HEK293 Cells
Humans
Immunotoxins--isolation & purification
Neoplasms--drug therapy
Recombinant Proteins--isolation & purification
Single-Domain Antibodies--therapeutic use
Vascular Endothelial Growth Factor Receptor-2--immunology
Virulence Factors--pharmacology
Pseudomonas aeruginosa Exotoxin A